Monksdream
12 months ago
Arcturus Therapeutics Holdings Inc NASDAQ: ARCT
GoSymbol lookup
Health Care : Biotechnology | Small Cap GrowthCompany profile
Arcturus Therapeutics Holdings Inc. is a global late-stage clinical messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose level. It is leveraging its LUNAR platform
and its nucleic acid technologies to develop and advance a pipeline of mRNA-based vaccines and therapeutics for infectious diseases and rare genetic disorders with significant unmet medical needs. Its COVID-19 vaccine candidate, which is based on its STARR technology platform is through Phase II clinical trials.
Arcturus Therapeutics (ARCT)
icon-rise-1
15%
Shares of Arcturus Therapeutics traded up ~15% on Friday after the company’s vaccine, ARCT-154, demonstrated6 an improvement in immunogenicity—43% more neutralizing antibodies at a lower dose than Comirnaty®. Arcturus Therapeutics develops mRNA-based vaccines and therapeutics for the treatment of infectious and rare genetic diseases.
Arcturus Therapeutics (ARCT)
icon-rise-1
15%
Shares of Arcturus Therapeutics traded up ~15% on Friday after the company’s vaccine, ARCT-154, demonstrated6 an improvement in immunogenicity—43% more neutralizing antibodies at a lower dose than Comirnaty®. Arcturus Therapeutics develops mRNA-based vaccines and therapeutics for the treatment of infectious and rare genetic diseases.
Arcturus Therapeutics (ARCT)
icon-rise-1
15%
Shares of Arcturus Therapeutics traded up ~15% on Friday after the company’s vaccine, ARCT-154, demonstrated6 an improvement in immunogenicity—43% more neutralizing antibodies at a lower dose than Comirnaty®. Arcturus Therapeutics develops mRNA-based vaccines and therapeutics for the treatment of infectious and rare genetic diseases.
Willymon
4 years ago
$ARCT - $13.90 is sooner. Nobody here is even aware of them. And, with only 1100 on stocktwits, nobody there is aware.
If you buy at $50 and it goes to $110, you're still in profit. But, now we're into the "What IF" game. Have to be long on $ARCT.
If they come up with the Covid-19 vaccine, then that also means they also cured thousands of other viruses.
Their method is to provide humans with a way to clog the keyholes that the spikes on viruses need to plug into to infect and replicate.
They don't patent some of their methods on purpose because a patent must show exactly how something works. This is to their advantage so other biotech companies have to go figure it out on their own. Trade secret.
Willymon
4 years ago
$ARCT - PPS too high for iHubers and is not a OTC stock.
6 Followers iHub
1,091 Followers StockTwits (Only ~40 new followers in three weeks)
4,475 Followers SeekingAlpha (Their board is also inactive)
You said you are in $INO
596 Followers iHub
46,075 Followers StockTwits
43,563 Followers SeekingAlpha
Anything over $7, the chatter will be somewhere else. Especially if its not a OTC stock.
But, $ARCT is very promising for an ultra vaccine solution to the world.
Did you catch that they sold 2MM shares at $10/share to two investment firms as an additional capital raise. Listen to their last call on SeekingAlpha if you haven't already.
To me, than means if those firms did their homework, then they are looking for 10x return.
That means $ARCT which is at $17 will go to over +$100 if they can pull it off.
Not only are they working for vaccine solution, but they are doing it in a way that will scale production to supply the world, quick.
Think of the volume in the syringe of your last flu shot and then with $ARCT solution you would only need 1/100 the dose. I think its actually less - 1/1000?
Been buying since it was at $12
Sure would be nice to have 1MM shares of $ARCT